Using a new composite nanoparticle catalyst, researchers have shown they can make degradation-resistant PBO, a polymer used to make body armor and other high-performance fabrics.
Read moreIn Germany alone there are around 400,000 patients who suffer from chronic inflammatory bowel diseases. For the first time, researchers have discovered that dysfunctions in blood vessels play a significant role in the development of such diseases. In experimental model systems, the progression of the disease slowed down significantly by eliminating these dysfunctions.
Read moreMIT engineers designed a drug capsule that can carry insulin or other protein drugs and protect them from the harsh environment of the gastrointestinal tract. When the capsule reaches the small intestine, it breaks down to reveal dissolvable microneedles that attach to the intestinal wall and release drug for uptake into the bloodstream.
Read moreSmelly flatulence is one way our bodies manage our well-being. It turns out expelling noxious gas takes priority in our guts.
Read moreFindings showcasing a connection between bacteria in the microbiome and colon cancer, which may be used to screen younger populations at risk.
Read moreShift work and jet lag disrupt not just sleep cycles, but feeding and digestive cycles as well. Such disruptions have been linked to risk of obesity, inflammatory bowel disease, infection, and other conditions. Now, researchers have identified an immune cell that helps set the daily rhythms of the gut. The findings open the door to new treatments for digestive ailments targeting such cells.
Read moreNew research has found that a diet low in fermented carbohydrates has improved certain gut symptoms and improved health-related quality of life for sufferers of inflammatory bowel disease (IBD).
Read moreResearchers have developed an innovative drug treatment for familial adenomatous polyposis (FAP), a rare, inherited condition that affects adolescents and young adults and often leads to colorectal cancer.
Read moreTaking a 'fingerprint' of the mix of bacteria in the gut can indicate how susceptible individual cancer patients are to gut damage as a result of radiotherapy for prostate and gynaecological cancers, a new study shows. Researchers showed that having a reduced diversity of gut bacteria was associated with an increased risk of both immediate and delayed damage to the gut following radiotherapy.
Read moreRoutine testing for bowel cancer should not be recommended for everyone aged 50-79 years because, for those at very low risk, the benefit is small and uncertain and there are potential harms, say a panel of international experts.
Read more